Data Ocean connects Google Analytics, Search Console, page-level behavior, geography, keywords, and BioIntelligence into one operating layer for CDMO routing, content strategy, and market signal interpretation. Current view: 30D.
Real GA4 geography from CDMO Network, grouped by city/country and weighted by sessions/views.
Real Google Search Console keyword signals from CDMO Network.
| Keyword | Cluster | Imp. | Clicks | CTR | Pos. | Score |
|---|---|---|---|---|---|---|
| cdmo biotech | CDMO search | 124 | 0 | 0.00% | 46.89 | 1260.00 |
| cdmo biopharma | Biopharma CDMO | 108 | 0 | 0.00% | 74.30 | 1080.00 |
| carbohydrate cdmo services | CDMO search | 59 | 0 | 0.00% | 66.36 | 590.00 |
| biopharmaceutical cdmo | Biopharma CDMO | 48 | 0 | 0.00% | 45.91 | 500.00 |
| biopharma cdmo | Biopharma CDMO | 39 | 0 | 0.00% | 52.76 | 410.00 |
| bispecific antibodies cdmo | CDMO search | 37 | 0 | 0.00% | 40.37 | 390.00 |
| antibody cdmo | CDMO search | 35 | 0 | 0.00% | 46.54 | 370.00 |
| biotech cdmo | CDMO search | 28 | 0 | 0.00% | 48.27 | 300.00 |
| cdmo | CDMO search | 26 | 0 | 0.00% | 45.16 | 280.00 |
| alternative to lentiviral cdmo | CDMO search | 26 | 0 | 0.00% | 58.78 | 280.00 |
| biopharmaceuticals cdmo | Biopharma CDMO | 22 | 0 | 0.00% | 22.79 | 270.00 |
| cdmo biologicals | CDMO search | 21 | 0 | 0.00% | 63.74 | 210.00 |
| cdmo cell and gene therapy | CDMO search | 21 | 0 | 0.00% | 69.01 | 210.00 |
| biosimilar cdmo | CDMO search | 19 | 0 | 0.00% | 48.33 | 210.00 |
| cdmo bioprocess development | CDMO search | 13 | 0 | 0.00% | 11.32 | 180.00 |
| ("crdmo" or "cdmo" or "cro" or "contract research" or "contract development" or "manufacturing organization" or "contract research organization" or "contract development and manufacturing organization" or "monoclonal antibodies") | CDMO search | 16 | 0 | 0.00% | 65.06 | 160.00 |
| best gene therapy cdmo | CDMO search | 13 | 0 | 0.00% | 56.67 | 150.00 |
| biomanufacturing cdmo | CDMO search | 11 | 0 | 0.00% | 34.56 | 130.00 |
| "replication-competent lentivirus" commercial supplier | General search | 2 | 0 | 0.00% | 6.00 | 120.00 |
| aav release testing sterility endotoxin mycoplasma residual host cell dna potency review | General search | 1 | 0 | 0.00% | 6.00 | 110.00 |
| aav release testing identity potency purity sterility mycoplasma endotoxin review | General search | 1 | 0 | 0.00% | 8.00 | 110.00 |
| biologics drug substance manufacturing | General search | 8 | 0 | 0.00% | 50.67 | 100.00 |
| ("crdmo" or "contract research, development, and manufacturing organization" or "cdmo" or "contract development and manufacturing organization" or "cro" or "contract research organization" or "drug development" or "pharmaceutical outsourcing" or "drug discovery outsourcing") | CDMO search | 8 | 0 | 0.00% | 58.00 | 100.00 |
| cdmo cell therapy | CDMO search | 8 | 0 | 0.00% | 63.33 | 80.00 |
| biologics supply chain | General search | 3 | 0 | 0.00% | 24.67 | 80.00 |
| bulk drug manufacturing | General search | 7 | 0 | 0.00% | 64.25 | 70.00 |
| best cdmo company for allogeneic cell therapy | CDMO search | 7 | 0 | 0.00% | 77.50 | 70.00 |
| cdmo advertising | CDMO search | 7 | 0 | 0.00% | 81.71 | 70.00 |
| cdmo logistics | Supply chain / logistics | 2 | 0 | 0.00% | 27.00 | 70.00 |
| best cdmo company for autologous cell therapy | CDMO search | 6 | 0 | 0.00% | 82.00 | 60.00 |
| audit ready biologics cdmo | CDMO search | 1 | 0 | 0.00% | 14.00 | 60.00 |
| aav capsid | General search | 1 | 0 | 0.00% | 17.00 | 60.00 |
| cdmo batch record | CDMO search | 1 | 0 | 0.00% | 20.00 | 60.00 |
| cdmo biologics services | CDMO search | 5 | 0 | 0.00% | 81.00 | 50.00 |
| caplin steriles cdmo sterile fill-finish lyophilization injectable vials contract manufacturing https://caplinsteriles.com | CDMO search | 3 | 0 | 0.00% | 39.00 | 50.00 |
| aav vector cdmo services | CDMO search | 4 | 0 | 0.00% | 69.75 | 40.00 |
| alternative to current cdmo microbial | Microbial / fermentation | 4 | 0 | 0.00% | 73.67 | 40.00 |
| allogeneic cell therapy cdmo | CDMO search | 2 | 0 | 0.00% | 42.00 | 40.00 |
| cdmo gene therapy | CDMO search | 2 | 0 | 0.00% | 55.50 | 40.00 |
| aav vector cdmo | CDMO search | 3 | 0 | 0.00% | 69.00 | 30.00 |
| cdmo analytique | CDMO search | 1 | 0 | 0.00% | 32.00 | 30.00 |
| autologous cell therapy cdmo | CDMO search | 1 | 0 | 0.00% | 37.00 | 30.00 |
| biopharmaceuticals cmo | Biopharma CDMO | 1 | 0 | 0.00% | 38.00 | 30.00 |
| bispecific antibody cdmo | CDMO search | 1 | 0 | 0.00% | 39.00 | 30.00 |
| biologics cold chain solutions | Supply chain / logistics | 1 | 0 | 0.00% | 39.00 | 30.00 |
| biotherapeutics discovery cdmo | CDMO search | 1 | 0 | 0.00% | 40.00 | 30.00 |
| cdmo capabilities | CDMO search | 1 | 0 | 0.00% | 44.00 | 30.00 |
| biologics reagent manufacturing | Research tools / reagents | 1 | 0 | 0.00% | 47.00 | 30.00 |
| best gene therapy cdmo? | CDMO search | 1 | 0 | 0.00% | 47.00 | 30.00 |
| car t cell therapy cdmo development services | CDMO search | 1 | 0 | 0.00% | 52.00 | 30.00 |
| biosimilar cdmo selection criteria | CDMO search | 1 | 0 | 0.00% | 59.00 | 30.00 |
| cdmo batch records | CDMO search | 1 | 0 | 0.00% | 60.00 | 30.00 |
| cdmo for difficult proteins | Protein expression | 2 | 0 | 0.00% | 63.50 | 20.00 |
| bacterial cdmo | CDMO search | 2 | 0 | 0.00% | 65.50 | 20.00 |
| biologics pharmaceuticals cdmo | CDMO search | 2 | 0 | 0.00% | 71.00 | 20.00 |
| ("antibody drug conjugates" or "adcs" or "cell line development" or "small molecule manufacturing" or "clinical manufacturing" or "commercial manufacturing" or "ai in drug discovery" or "pharmaceutical innovation" or "pharma r&d") | Cell / strain engineering | 2 | 0 | 0.00% | 100.50 | 20.00 |
| cdmo business development services | CDMO search | 1 | 0 | 0.00% | 65.00 | 10.00 |
| batch-to-batch consistent neural assay reagents for automated mps | Research tools / reagents | 1 | 0 | 0.00% | 69.00 | 10.00 |
| cdmo batch manufacturing software | CDMO search | 1 | 0 | 0.00% | 70.00 | 10.00 |
| adc fill finish | General search | 1 | 0 | 0.00% | 73.00 | 10.00 |
| analytical manufacturing cdmo | CDMO search | 1 | 0 | 0.00% | 79.00 | 10.00 |
| biotherapeutics manufacturing infrastructure cdmo | CDMO search | 1 | 0 | 0.00% | 81.00 | 10.00 |
| cdmo for biotech | CDMO search | 1 | 0 | 0.00% | 87.00 | 10.00 |
| carcinogenicity testing services cdmo | CDMO search | 1 | 0 | 0.00% | 88.00 | 10.00 |
| cdmo advanced therapy | CDMO search | 1 | 0 | 0.00% | 88.00 | 10.00 |
GA4 sessions by country.
| Country | Sessions | Users |
|---|---|---|
| AUS | 0 | 0 |
| IND | 0 | 0 |
| EGY | 0 | 0 |
| FRA | 0 | 0 |
| NLD | 0 | 0 |
| GEO | 0 | 0 |
| ARG | 0 | 0 |
| USA | 0 | 0 |
| AUT | 0 | 0 |
| CAN | 0 | 0 |
| BRA | 0 | 0 |
| RUS | 0 | 0 |
| BGD | 0 | 0 |
| NGA | 0 | 0 |
| GBR | 0 | 0 |
| IRN | 0 | 0 |
| CHE | 0 | 0 |
| PRT | 0 | 0 |
| PAK | 0 | 0 |
| HKG | 0 | 0 |
| BEL | 0 | 0 |
| ITA | 0 | 0 |
| CZE | 0 | 0 |
| VNM | 0 | 0 |
| NZL | 0 | 0 |
| UKR | 0 | 0 |
| DZA | 0 | 0 |
| NOR | 0 | 0 |
| JPN | 0 | 0 |
| PHL | 0 | 0 |
| BLZ | 0 | 0 |
| DNK | 0 | 0 |
| MEX | 0 | 0 |
| POL | 0 | 0 |
| SWE | 0 | 0 |
| DEU | 0 | 0 |
| ESP | 0 | 0 |
| IDN | 0 | 0 |
Local demand points.
| City | Country | Sessions |
|---|---|---|
| Unknown | BEL | 0 |
| Unknown | AUT | 0 |
| Unknown | PRT | 0 |
| Unknown | FRA | 0 |
| Unknown | HKG | 0 |
| Unknown | GEO | 0 |
| Unknown | IND | 0 |
| Unknown | JPN | 0 |
| Unknown | ARG | 0 |
| Unknown | NZL | 0 |
| Unknown | NGA | 0 |
| Unknown | ESP | 0 |
| Unknown | NOR | 0 |
| Unknown | EGY | 0 |
| Unknown | CHE | 0 |
| Unknown | IDN | 0 |
| Unknown | PAK | 0 |
| Unknown | BGD | 0 |
| Unknown | RUS | 0 |
| Unknown | AUS | 0 |
| Unknown | BLZ | 0 |
| Unknown | CAN | 0 |
| Unknown | USA | 0 |
| Unknown | DEU | 0 |
| Unknown | MEX | 0 |
| Unknown | CZE | 0 |
| Unknown | PHL | 0 |
| Unknown | BRA | 0 |
| Unknown | ITA | 0 |
| Unknown | NLD | 0 |
| Unknown | SWE | 0 |
| Unknown | POL | 0 |
| Unknown | GBR | 0 |
| Unknown | DZA | 0 |
| Unknown | VNM | 0 |
| Unknown | IRN | 0 |
| Unknown | DNK | 0 |
| Unknown | UKR | 0 |
Search Console demand terms Google is surfacing CDMO Network for.
| Keyword | Country | Clicks | Imp. | Pos. |
|---|---|---|---|---|
| biopharma cdmo | USA | 0 | 34 | 50.95 |
| antibody cdmo | USA | 0 | 32 | 46.95 |
| biopharmaceutical cdmo | USA | 0 | 26 | 52.87 |
| alternative to lentiviral cdmo | USA | 0 | 26 | 58.78 |
| cdmo biopharma | NLD | 0 | 26 | 83.36 |
| bispecific antibodies cdmo | USA | 0 | 25 | 42.48 |
| cdmo biotech | USA | 0 | 23 | 53.89 |
| cdmo biotech | NLD | 0 | 22 | 46.07 |
| cdmo biopharma | BEL | 0 | 22 | 84.18 |
| cdmo biologicals | BEL | 0 | 21 | 63.74 |
| cdmo biotech | DEU | 0 | 18 | 45.23 |
| cdmo biotech | BEL | 0 | 18 | 47.91 |
| biosimilar cdmo | USA | 0 | 18 | 48.45 |
| cdmo biopharma | SWE | 0 | 17 | 60.94 |
| cdmo biopharma | DNK | 0 | 17 | 61.47 |
| ("crdmo" or "cdmo" or "cro" or "contract research" or "contract development" or "manufacturing organization" or "contract research organization" or "contract development and manufacturing organization" or "monoclonal antibodies") | IND | 0 | 16 | 65.06 |
| carbohydrate cdmo services | USA | 0 | 16 | 72.63 |
| cdmo biotech | SWE | 0 | 15 | 41.50 |
| carbohydrate cdmo services | JPN | 0 | 14 | 54.69 |
| biopharmaceuticals cdmo | FRA | 0 | 13 | 14.15 |
| cdmo | POL | 0 | 13 | 27.95 |
| biopharmaceutical cdmo | CHE | 0 | 13 | 45.27 |
| biotech cdmo | USA | 0 | 13 | 52.00 |
| cdmo biopharma | DEU | 0 | 13 | 77.62 |
| cdmo biopharma | USA | 0 | 12 | 73.03 |
| cdmo bioprocess development | USA | 0 | 11 | 12.28 |
| carbohydrate cdmo services | NZL | 0 | 10 | 69.50 |
| cdmo cell and gene therapy | USA | 0 | 9 | 83.42 |
| biologics drug substance manufacturing | USA | 0 | 8 | 50.67 |
| ("crdmo" or "contract research, development, and manufacturing organization" or "cdmo" or "contract development and manufacturing organization" or "cro" or "contract research organization" or "drug development" or "pharmaceutical outsourcing" or "drug discovery outsourcing") | IND | 0 | 8 | 58.00 |
| carbohydrate cdmo services | AUS | 0 | 8 | 69.38 |
| bispecific antibodies cdmo | GBR | 0 | 7 | 36.58 |
| bulk drug manufacturing | GBR | 0 | 7 | 64.25 |
| best cdmo company for allogeneic cell therapy | USA | 0 | 7 | 77.50 |
| cdmo biotech | DNK | 0 | 6 | 40.33 |
| carbohydrate cdmo services | CAN | 0 | 6 | 67.50 |
| best cdmo company for autologous cell therapy | USA | 0 | 6 | 82.00 |
| best gene therapy cdmo | DEU | 0 | 5 | 56.40 |
| carbohydrate cdmo services | GBR | 0 | 5 | 71.00 |
| cdmo biologics services | USA | 0 | 5 | 81.00 |
| biomanufacturing cdmo | CAN | 0 | 4 | 40.00 |
| biopharmaceuticals cdmo | USA | 0 | 4 | 47.83 |
| best gene therapy cdmo | GBR | 0 | 4 | 59.67 |
| aav vector cdmo services | USA | 0 | 4 | 69.75 |
| alternative to current cdmo microbial | USA | 0 | 4 | 73.67 |
| cdmo advertising | USA | 0 | 4 | 77.50 |
| biopharmaceutical cdmo | FRA | 0 | 3 | 19.00 |
| biopharmaceuticals cdmo | NOR | 0 | 3 | 24.00 |
| biologics supply chain | USA | 0 | 3 | 24.67 |
| caplin steriles cdmo sterile fill-finish lyophilization injectable vials contract manufacturing https://caplinsteriles.com | CAN | 0 | 3 | 39.00 |
| bispecific antibodies cdmo | CHE | 0 | 3 | 41.67 |
| cdmo biotech | ESP | 0 | 3 | 48.67 |
| cdmo biotech | GBR | 0 | 3 | 50.67 |
| cdmo cell and gene therapy | DEU | 0 | 3 | 54.25 |
| cdmo | USA | 0 | 3 | 57.00 |
| biotech cdmo | UKR | 0 | 3 | 57.00 |
| aav vector cdmo | USA | 0 | 3 | 69.00 |
| cdmo advertising | GBR | 0 | 3 | 87.33 |
| "replication-competent lentivirus" commercial supplier | USA | 0 | 2 | 6.00 |
| cdmo bioprocess development | GBR | 0 | 2 | 7.00 |
| biomanufacturing cdmo | FRA | 0 | 2 | 16.50 |
| cdmo logistics | GBR | 0 | 2 | 27.00 |
| biotech cdmo | IND | 0 | 2 | 31.00 |
| biopharmaceutical cdmo | NOR | 0 | 2 | 35.50 |
| biotech cdmo | BLZ | 0 | 2 | 37.50 |
| biomanufacturing cdmo | GBR | 0 | 2 | 40.50 |
| biomanufacturing cdmo | USA | 0 | 2 | 40.50 |
| cdmo biotech | VNM | 0 | 2 | 44.00 |
| cdmo biotech | IND | 0 | 2 | 46.00 |
| biopharma cdmo | AUS | 0 | 2 | 47.00 |
| cdmo biotech | EGY | 0 | 2 | 49.50 |
| best gene therapy cdmo | ITA | 0 | 2 | 53.50 |
| best gene therapy cdmo | USA | 0 | 2 | 56.00 |
| cdmo cell therapy | GBR | 0 | 2 | 60.00 |
| cdmo for difficult proteins | USA | 0 | 2 | 63.50 |
| cdmo cell therapy | PRT | 0 | 2 | 65.00 |
| bacterial cdmo | USA | 0 | 2 | 65.50 |
| cdmo biotech | JPN | 0 | 2 | 67.00 |
| cdmo cell and gene therapy | BLZ | 0 | 2 | 72.00 |
| cdmo cell therapy | MEX | 0 | 2 | 72.00 |
| biotech cdmo | PAK | 0 | 2 | 72.00 |
| biopharma cdmo | NLD | 0 | 2 | 78.00 |
| ("antibody drug conjugates" or "adcs" or "cell line development" or "small molecule manufacturing" or "clinical manufacturing" or "commercial manufacturing" or "ai in drug discovery" or "pharmaceutical innovation" or "pharma r&d") | IND | 0 | 2 | 100.50 |
| aav release testing sterility endotoxin mycoplasma residual host cell dna potency review | USA | 0 | 1 | 6.00 |
| aav release testing identity potency purity sterility mycoplasma endotoxin review | USA | 0 | 1 | 8.00 |
| audit ready biologics cdmo | POL | 0 | 1 | 14.00 |
| aav capsid | NLD | 0 | 1 | 17.00 |
| cdmo batch record | DEU | 0 | 1 | 20.00 |
| cdmo | AUT | 0 | 1 | 23.00 |
| bispecific antibodies cdmo | NLD | 0 | 1 | 28.00 |
| cdmo analytique | CAN | 0 | 1 | 32.00 |
| biotech cdmo | CZE | 0 | 1 | 34.00 |
| biomanufacturing cdmo | DEU | 0 | 1 | 36.00 |
| biotech cdmo | CAN | 0 | 1 | 36.00 |
| antibody cdmo | NLD | 0 | 1 | 36.00 |
| autologous cell therapy cdmo | USA | 0 | 1 | 37.00 |
| biopharmaceuticals cdmo | GBR | 0 | 1 | 38.00 |
| biopharmaceuticals cmo | ITA | 0 | 1 | 38.00 |
| bispecific antibody cdmo | NLD | 0 | 1 | 39.00 |
| biologics cold chain solutions | USA | 0 | 1 | 39.00 |
Positions 8–30. Best near-term SEO targets.
| Keyword | Imp. | Pos. |
|---|---|---|
| biopharmaceuticals cdmo | 13 | 14.15 |
| cdmo | 12 | 24.18 |
| cdmo bioprocess development | 10 | 12.94 |
| biopharmaceutical cdmo | 3 | 19.00 |
| biopharmaceuticals cdmo | 3 | 24.00 |
| biologics supply chain | 3 | 24.67 |
| biomanufacturing cdmo | 2 | 16.50 |
| cdmo biotech | 2 | 25.50 |
| cdmo logistics | 2 | 27.00 |
| cdmo bioprocess development | 1 | 8.00 |
| aav release testing identity potency purity sterility mycoplasma endotoxin review | 1 | 8.00 |
| "replication-competent lentivirus" commercial supplier | 1 | 8.00 |
| audit ready biologics cdmo | 1 | 14.00 |
| aav capsid | 1 | 17.00 |
| cdmo batch record | 1 | 20.00 |
| cdmo | 1 | 23.00 |
| biopharmaceutical cdmo | 1 | 25.00 |
| bispecific antibodies cdmo | 1 | 28.00 |
Content and title/meta improvement targets based on real GSC data.
| Keyword | Country | CTR | Imp. | Pos. |
|---|---|---|---|---|
| biopharmaceuticals cdmo | FRA | 0% | 13 | 14.15 |
| cdmo bioprocess development | USA | 0% | 10 | 12.94 |
| biopharmaceutical cdmo | FRA | 0% | 3 | 19.00 |
| biomanufacturing cdmo | FRA | 0% | 2 | 16.50 |
| aav release testing identity potency purity sterility mycoplasma endotoxin review | USA | 0% | 1 | 8.00 |
| "replication-competent lentivirus" commercial supplier | USA | 0% | 1 | 8.00 |
| cdmo bioprocess development | GBR | 0% | 1 | 8.00 |
| audit ready biologics cdmo | POL | 0% | 1 | 14.00 |
| aav capsid | NLD | 0% | 1 | 17.00 |
| cdmo batch record | DEU | 0% | 1 | 20.00 |
| cdmo | POL | 0% | 12 | 24.18 |
| bispecific antibodies cdmo | GBR | 0% | 4 | 34.83 |
| biopharmaceuticals cdmo | NOR | 0% | 3 | 24.00 |
| biologics supply chain | USA | 0% | 3 | 24.67 |
| cdmo logistics | GBR | 0% | 2 | 27.00 |
| biotech cdmo | IND | 0% | 2 | 31.00 |
| cdmo | AUT | 0% | 1 | 23.00 |
| bispecific antibodies cdmo | NLD | 0% | 1 | 28.00 |
| cdmo analytique | CAN | 0% | 1 | 32.00 |
| biotech cdmo | CZE | 0% | 1 | 34.00 |
| biopharmaceutical cdmo | NOR | 0% | 1 | 35.00 |
| biopharma cdmo | USA | 0% | 21 | 49.42 |
| cdmo biotech | USA | 0% | 20 | 53.85 |
| biopharmaceutical cdmo | USA | 0% | 19 | 54.00 |
| bispecific antibodies cdmo | USA | 0% | 18 | 42.67 |
| antibody cdmo | USA | 0% | 18 | 46.14 |
| cdmo biologicals | BEL | 0% | 18 | 63.02 |
| ("crdmo" or "cdmo" or "cro" or "contract research" or "contract development" or "manufacturing organization" or "contract research organization" or "contract development and manufacturing organization" or "monoclonal antibodies") | IND | 0% | 16 | 65.06 |
| biosimilar cdmo | USA | 0% | 12 | 50.80 |
| cdmo biotech | NLD | 0% | 11 | 46.03 |
| cdmo biopharma | USA | 0% | 11 | 73.63 |
| cdmo biopharma | NLD | 0% | 11 | 83.63 |
| ("crdmo" or "contract research, development, and manufacturing organization" or "cdmo" or "contract development and manufacturing organization" or "cro" or "contract research organization" or "drug development" or "pharmaceutical outsourcing" or "drug discovery outsourcing") | IND | 0% | 8 | 58.00 |
| cdmo cell and gene therapy | USA | 0% | 8 | 81.89 |
| cdmo biotech | DEU | 0% | 7 | 43.38 |
| carbohydrate cdmo services | USA | 0% | 7 | 72.83 |
| cdmo biotech | SWE | 0% | 6 | 42.00 |
| alternative to lentiviral cdmo | USA | 0% | 6 | 60.67 |
| biotech cdmo | USA | 0% | 5 | 52.33 |
| cdmo biotech | BEL | 0% | 4 | 36.75 |
| biomanufacturing cdmo | CAN | 0% | 4 | 40.00 |
| biopharmaceutical cdmo | CHE | 0% | 4 | 47.50 |
| biologics drug substance manufacturing | USA | 0% | 4 | 54.50 |
| carbohydrate cdmo services | GBR | 0% | 4 | 70.50 |
| best cdmo company for allogeneic cell therapy | USA | 0% | 4 | 76.75 |
| caplin steriles cdmo sterile fill-finish lyophilization injectable vials contract manufacturing https://caplinsteriles.com | CAN | 0% | 3 | 39.00 |
| biotech cdmo | UKR | 0% | 3 | 57.00 |
| best cdmo company for autologous cell therapy | USA | 0% | 3 | 86.00 |
| biopharmaceuticals cdmo | USA | 0% | 2 | 47.50 |
| cdmo cell and gene therapy | DEU | 0% | 2 | 56.50 |
| carbohydrate cdmo services | JPN | 0% | 2 | 57.00 |
| best gene therapy cdmo | GBR | 0% | 2 | 59.00 |
| bulk drug manufacturing | GBR | 0% | 2 | 62.50 |
| cdmo for difficult proteins | USA | 0% | 2 | 63.50 |
| cdmo biopharma | SWE | 0% | 2 | 64.00 |
| cdmo cell therapy | PRT | 0% | 2 | 65.00 |
| cdmo biotech | JPN | 0% | 2 | 67.00 |
| cdmo | USA | 0% | 2 | 69.00 |
| alternative to current cdmo microbial | USA | 0% | 2 | 69.00 |
| cdmo cell and gene therapy | BLZ | 0% | 2 | 72.00 |
| biotech cdmo | PAK | 0% | 2 | 72.00 |
| cdmo cell therapy | MEX | 0% | 2 | 72.00 |
| cdmo biologics services | USA | 0% | 2 | 80.00 |
Download Excel-compatible CSV files for reporting, analysis, investor materials, and external BI tools.
Latest generated Data Ocean / BioIntelligence report.